Details for Patent: 8,785,415
✉ Email this page to a colleague
Which drugs does patent 8,785,415 protect, and when does it expire?
Patent 8,785,415 protects MAVENCLAD and is included in one NDA.
This patent has sixty-eight patent family members in thirty-one countries.
Summary for Patent: 8,785,415
| Title: | Oral formulations of cladribine |
| Abstract: | Provided are compositions of cladribine and cyclodextrin which are especially suited for the oral administration of cladribine. |
| Inventor(s): | Bodor; Nicholas S. (Bal Harbour, FL), Dandiker; Yogesh (Toronto, CA) |
| Assignee: | Ares Trading S.A. (Aubonne, CH) |
| Application Number: | 12/986,310 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Process; Dosage form; |
Drugs Protected by US Patent 8,785,415
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono Inc | MAVENCLAD | cladribine | TABLET;ORAL | 022561-001 | Mar 29, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF MS WITH AN ADMIXTURE OF (A) AN AMORPHOUS INCLUSION COMPLEX OF CLADRIBINE (2CDA) AND CYCLODEXTRIN AND (B) AMORPHOUS FREE 2CDA AND CYCLODEXTRIN AS A NON-INCLUSION COMPLEX, FORMULATED AS A SOLID ORAL FORM, W/O SIGN. AMOUNTS OF CRYST. 2CDA | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,785,415
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 476177 | ⤷ Try a Trial | |||
| Australia | 2004226435 | ⤷ Try a Trial | |||
| Australia | 2004226437 | ⤷ Try a Trial | |||
| Australia | 2009227811 | ⤷ Try a Trial | |||
| Australia | 2010214777 | ⤷ Try a Trial | |||
| Australia | 2013203873 | ⤷ Try a Trial | |||
| Brazil | 122018068797 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
